This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • ADHD
  • /
  • Clinical Efficacy and Long Term Effects of Transcr...
Clinical trial

Clinical Efficacy and Long Term Effects of Transcranial Direct Current Stimulation (tDCS) in Children With Attention Deficit/​Hyperactivity Disorder (ADHD) (STIMADHD)

Read time: 1 mins
Last updated:21st Mar 2023
Status: RECRUITING
Identifier: NCT04704687
Clinical Efficacy and Long Term Effects of Transcranial Direct Current Stimulation (tDCS) in Children With Attention Deficit/​Hyperactivity Disorder (ADHD) (STIMADHD)


ClinicalTrials.gov ID: NCT04704687

Sponsor: Centre Hospitalier Universitaire, Amiens
Information provided by: Centre Hospitalier Universitaire, Amiens (Responsible Party)
Last Update Posted: 2023-03-22

Brief Summary:
Attention-Deficit/Hyperactivity Disorder (ADHD) is the most commonly diagnosed neurodevelopmental disorder in childhood. Patients with ADHD present inattention, impulsivity and hyperactivity causing severe impairments on academic achievement, social and professional life and daily functioning. Medications are effective in a majority of children with ADHD, but about 30% do not respond or tolerate stimulants, and some parents refuse pharmacological treatments.Transcranial Direct Current Stimulation is a safe and non-invasive technique of brain stimulation used in several neurological and psychiatric disorders, and recently in ADHD. In patients with ADHD, tDCS stimulations targeted frontal regions improve executive and attentional functioning and daily life symptoms. The objective of this project is to evaluate the efficacy of tDCS (vs sham) during cognitive-remediation exercises on ADHD symptoms (inattention, impulsivity and hyperactivity as defined by DSM-5) in children with ADHD between 7 and 14 years of age.

Official Title:
Clinical Efficacy and Long Term Effects of Transcranial Direct Current Stimulation (tDCS) in Children With Attention Deficit/Hyperactivity Disorder (ADHD)

Intervention / Treatment:
- Other: Transcranial Direct Current Stimulation

Category Value
Study Start (Actual) 2021-01-08
Primary Completion (Estimated)
2025-08
Study Completion (Estimated) 2026-01
Enrollment (Estimated) 150
Study Type Interventional
Phase Not Applicable
Other Study ID Numbers

PI2018_843_0069

View full details